₹2.35
(Market cap
₹75 Cr
Revenue (TTM)
₹15 Cr
P/E Ratio
337.1
P/B Ratio
3.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
1 %
-
ROCE
4.2 %
-
Industry P/E
48.01
-
EV/EBITDA
62
-
Debt to Equity
0.1
-
Book Value
₹16.5
-
EPS
₹0.2
-
Face value
10
-
Shares outstanding
15,250,000
6 Years Aggregate
CFO
₹-11.11 Cr
EBITDA
₹6.68 Cr
Net Profit
₹1.95 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Vilin Bio Med
| 135.8 | 32.6 | 37.2 | 94.9 | -- | -- | -- |
|
BSE Healthcare
| 7.1 | 11.7 | 10.9 | 10.9 | 26.2 | 14.1 | 11.7 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
Vilin Bio Med
| -4.8 | -6.4 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Healthcare
| -3.3 | 43.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Vilin Bio Med
|
49.4 | 75.3 | 14.8 | 0.2 | -- | 1 | 337.1 | 3.1 |
| 2,734.3 | 22,376.6 | 1,339.4 | 356.4 | 33.2 | 23.2 | 62.8 | 13.5 | |
| 488.2 | 18,680.8 | 2,051.5 | 180.5 | 11.6 | 7.7 | 92.6 | 4.9 | |
| 753.0 | 18,644.2 | 5,365.6 | 595.0 | 16.6 | 13.3 | 31.3 | 3.7 | |
| 1,174.7 | 21,027.5 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 13.5 | 2.4 | |
| 1,835.2 | 21,047.8 | 1,419.3 | 20.1 | 8.4 | 0.5 | 1047.1 | 3.6 | |
| 179.9 | 23,893.2 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.9 | |
| 955.8 | 15,761.4 | 1,284.3 | 134.4 | -- | 30.7 | 117.3 | 12.9 | |
| 458.1 | 18,488.1 | 3,738.7 | 316.7 | 12.5 | 7.5 | 58.4 | 3.8 | |
| 1,606.5 | 26,110.9 | 3,373.0 | 199.0 | 12.6 | 5.9 | 122.6 | 5.3 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Vilin Bio Med
Manufacture of pharmaceuticals, medicinal chemical and botanical products
-
Incorporated
2005
-
Chairman
--
-
Managing Director
Madhusudhan Reddy
-
Headquarters
Hyderabad, Telangana
-
Website
Looking for more details about Vilin Bio Med Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Vilin Bio Med
What is the current share price of Vilin Bio Med Ltd Today?
The share price of Vilin Bio Med Ltd is ₹49.40 (NSE) as of 08-May-2026 IST. Vilin Bio Med Ltd has given a return of 94.87% in the last 1 years.
What is the current PB & PE ratio of Vilin Bio Med Ltd?
The P/E ratio of Vilin Bio Med Ltd is 337.07 times as on 08-May-2026, a 602 premium to its peers’ median range of 48.01 times.
The P/B ratio of Vilin Bio Med Ltd is 3.09 times as on 08-May-2026, a 15 discount to its peers’ median range of 3.62 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
127.34
|
1.23
|
|
2024
|
163.23
|
1.16
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Vilin Bio Med Ltd?
The 52-week high and low of Vilin Bio Med Ltd are Rs 49.40 and Rs 18.95 as of 08-May-2026.
What is the market cap of Vilin Bio Med Ltd?
Vilin Bio Med Ltd has a market capitalisation of ₹ 75 Cr as on 08-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Vilin Bio Med Ltd?
Before investing in Vilin Bio Med Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.